Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03220347
Title A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene

marginal zone B-cell lymphoma

Advanced Solid Tumor

diffuse large B-cell lymphoma

follicular lymphoma

basal cell carcinoma



Age Groups: adult | senior
Covered Countries ITA | FRA | ESP

No variant requirements are available.